Pulmonx (LUNG) Operating Margin (2019 - 2025)
Pulmonx's (LUNG) quarterly Operating Margin came in at 66.94% in Q3 2025, up 237.0% year-on-year from 19.86% in Q3 2024, and down 7.88% on a QoQ basis from 62.05% in Q2 2025.
Pulmonx (LUNG) Operating Margin (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Operating Margin data on file, last reported at 66.94% in Q3 2025.
- On a quarterly basis, Operating Margin rose 237.0% year-over-year to 66.94% in Q3 2025; TTM through Sep 2025 was 62.38%, a 1102.0% increase from a year earlier, with the FY2024 full-year figure at 68.87%, up 2132.0% from the prior year.
- Operating Margin for Q3 2025 stood at 66.94%, down from 62.05% in the prior quarter.
- Over the last five years, Operating Margin for LUNG reached as high as 56.46% in Q4 2024 and fell as low as 145.28% in Q1 2022.
- Historically, Operating Margin has averaged 88.82% across 5 years, with a median of 85.9% in 2023.
- On a YoY basis, Operating Margin climbed as much as 20988 bps in 2021 and fell as far as 6433 bps in 2021.
- Year by year, Operating Margin stood at 90.21% in 2021, then fell by 5 bps to 94.83% in 2022, then grew by 24 bps to 72.2% in 2023, then rose by 22 bps to 56.46% in 2024, then declined by 19 bps to 66.94% in 2025.
- Per Business Quant data, the three most recent Operating Margin figures were 66.94% in Q3 2025, 62.05% in Q2 2025, and 64.62% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Pulmonx | 49.94 Mn | -19.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -66.94% |
| Jun 30, 2025 | -62.05% |
| Mar 31, 2025 | -64.62% |
| Dec 31, 2024 | -56.46% |
| Sep 30, 2024 | -69.30% |
| Jun 30, 2024 | -75.17% |
| Mar 31, 2024 | -77.10% |
| Dec 31, 2023 | -72.20% |
| Sep 30, 2023 | -85.90% |
| Jun 30, 2023 | -95.61% |
| Mar 31, 2023 | -112.83% |
| Dec 31, 2022 | -94.83% |
| Sep 30, 2022 | -103.18% |
| Jun 30, 2022 | -103.30% |
| Mar 31, 2022 | -145.28% |
| Dec 31, 2021 | -90.21% |
| Sep 30, 2021 | -73.61% |
| Jun 30, 2021 | -103.93% |
| Mar 31, 2021 | -135.16% |
| Dec 31, 2020 | -95.16% |